Equity Overview
Price & Market Data
Price: $0.681
Daily Change: -$0.0195 / 2.87%
Range: $0.681 - $0.74
Market Cap: $4,700,831
Volume: 9,484
Performance Metrics
1 Week: -0.27%
1 Month: 0.70%
3 Months: -27.04%
6 Months: -33.18%
1 Year: -62.37%
YTD: -29.21%
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.